G1 Therapeutics
GTHX
$4.49
Share price
1.13%
Change (1 day)
48.68%
Change (1 year)
Categories
P/S ratio for G1 Therapeutics (GTHX)
P/S ratio as of May 2024 (TTM): 2.81
According to G1 Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.81457. At the end of 2023 the company had a P/S ratio of 1.92.
P/S ratio history for G1 Therapeutics from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.92 | -64.23% |
| 2022 | 5.36 | -61.16% |
| 2021 | 13.8 | -8.74% |
| 2020 | 15.1 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |